Skip to main content

Amazon launches medication management features for Alexa

As Amazon moves further into the healthcare market, the company today is rolling out a medication management feature for Alexa owners. The feature will allow customers to set up their own medication reminders and request voice refills using their prescription information. At launch, these capabilities are only available to customers of Giant Eagle Pharmacy, a regional retailer in the Midwest and East Coast.

That being said, there are obvious ties to Amazon’s larger plans with regard to prescription management and healthcare. Amazon has now acquired two health startups, first with online pharmacy PillPack in 2018 for slightly less than $1 billion. This was followed by last month’s acquisition of Health Navigator, which will become a part of Amazon’s pilot healthcare service program for its employees, the recently launched Amazon Care.

The new Alexa features seem to be custom designed for integrations with both Amazon Care and PillPack prescription ordering, even though neither of the two services are referenced today as part of Amazon’s current or future plans with the Alexa features.

Asked about this, an Amazon spokesperson said only that the company would not “comment or speculate on the future.”

Instead, Amazon says it has teamed up with medication management solution and adherence tool provider Ominicell to enable the new features, which were inspired by how people were already using Alexa’s reminders system and other feedback.

For example, some customers said they would like to set time frames for reminders like “twice a day.”

To use the new Alexa medication management, customers will first need to enable the Giant Eagle Pharmacy skill and link their accounts. They’ll also need to create an Alexa voice profile, which helps Alexa to verify the person who is speaking, and they’ll need to create a personal passcode for an extra layer of security. Amazon notes that it had already rolled out a way for developers to build HIPAA-compliant skills using its platform, which not only includes the added authentication steps, but also redacts users’ interactions with the skill from the Alexa app for further privacy.

In addition, Amazon had also recently added a way for customers to view and delete recordings at any time, including from the Privacy Settings page, in the Alexa app, or by voice.

Once their account is set up, the customer can then say “Alexa, manage my medication” to get started setting up their reminders. Alexa will help the customer to review their current prescriptions and set up reminders based on when they prefer to take each medication.

When the reminders go off, customers can ask “Alexa, what medication am I supposed to take right now?”

When it’s time, customers can also use Alexa to request refills from the pharmacy by saying “Alexa, refill my prescription.”

The features, though limited to one regional pharmacy for the time being, offer a view into how Amazon envisions voice-ordering for prescriptions will work for its customer base, and how such a system could be integrated with its own health care program at some later date, perhaps.

“Voice has proven to be beneficial for a variety of use cases because it removes barriers, and simplifies daily tasks. We believe this new Alexa feature will help simplify the way people manage their medication by removing the need to continuously think about what medications they’ve taken that day or what they need to take,” noted Rachel Jiang, Head of Alexa Health & Wellness, in an announcement about the new features.

“We want to make it easy for people to get the information they need and to manage their healthcare needs at home while maintaining the privacy and security of their information, and hope this feature is a step toward that vision,” she added.

 

 



from TechCrunch https://ift.tt/33kwABl
via IFTTT

Comments

Popular posts from this blog

Max Q: Psyche(d)

In this issue: SpaceX launches NASA asteroid mission, news from Relativity Space and more. © 2023 TechCrunch. All rights reserved. For personal use only. from TechCrunch https://ift.tt/h6Kjrde via IFTTT

Max Q: Anomalous

Hello and welcome back to Max Q! Last week wasn’t the most successful for spaceflight missions. We’ll get into that a bit more below. In this issue: First up, a botched launch from Virgin Orbit… …followed by one from ABL Space Systems News from Rocket Lab, World View and more Virgin Orbit’s botched launch highlights shaky financial future After Virgin Orbit’s launch failure last Monday, during which the mission experienced an  “anomaly” that prevented the rocket from reaching orbit, I went back over the company’s financials — and things aren’t looking good. For Virgin Orbit, this year has likely been completely turned on its head. The company was aiming for three launches this year, but everything will remain grounded until the cause of the anomaly has been identified and resolved. It’s unclear how long that will take, but likely at least three months. Add this delay to Virgin’s dwindling cash reserves and you have a foundation that’s suddenly much shakier than before. ...

What’s Stripe’s deal?

Welcome to  The Interchange ! If you received this in your inbox, thank you for signing up and your vote of confidence. If you’re reading this as a post on our site, sign up  here  so you can receive it directly in the future. Every week, I’ll take a look at the hottest fintech news of the previous week. This will include everything from funding rounds to trends to an analysis of a particular space to hot takes on a particular company or phenomenon. There’s a lot of fintech news out there and it’s my job to stay on top of it — and make sense of it — so you can stay in the know. —  Mary Ann Stripe eyes exit, reportedly tried raising at a lower valuation The big news in fintech this week revolved around payments giant Stripe . On January 26, my Equity Podcast co-host and overall amazingly talented reporter Natasha Mascarenhas and I teamed up to write about how Stripe had set a 12-month deadline for itself to go public, either through a direct listing or by pursuin...